Alternatively, heregulin genomic induction increases the phosphorylation level of HER3, providing resistance to EGFR-inhibitors in EGFR-mutated NSCLC or CRC cells [23,24]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.